Weiwei Liao

Title: Weiwei Liao: Innovator in Pharmaceutical Chemistry

Introduction

Weiwei Liao is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tetrahydroisoquinoline derivatives. His research focuses on the preparation methods and applications of these compounds in medicine.

Latest Patents

Weiwei Liao holds a patent for a tetrahydroisoquinoline derivative, which includes a preparation method and its use in therapeutic applications. This patent details a compound represented by a specific general formula, along with its pharmaceutically acceptable salts. The invention is particularly relevant as it serves as an angiotensin II type 2 receptor (ATR) antagonist, showcasing its potential as a therapeutic agent.

Career Highlights

Weiwei Liao is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, contributing to the development of new therapeutic agents.

Collaborations

Weiwei has collaborated with notable colleagues such as Yanghui Guo and Xiangui Huang. These partnerships have enhanced his research capabilities and broadened the impact of his innovations in the field.

Conclusion

Weiwei Liao's contributions to pharmaceutical chemistry, particularly through his patent on tetrahydroisoquinoline derivatives, highlight his role as an innovator in the industry. His work continues to pave the way for advancements in medical therapies.